Phase I trial of platinum ethylenedicysteine glucosamine.
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2013
At a glance
- Drugs Platinum ethylenedicysteine glucosamine (Primary)
- Indications B cell lymphoma
- Focus Adverse reactions
- Sponsors CellPoint
- 19 Mar 2013 Planned initiation is during 2013, according to CellPoint pipeline.
- 27 Jan 2012 New trial record